Treatment device and system for biomedical tuberculosis ward pollutants

Abstract

The invention relates to the technical field of pollutant disinfection treatment, in particular to a treatment device and system for biomedical tuberculosis ward pollutants, which comprises a breathing mask, a treatment system for biomedical tuberculosis ward pollutants, an exhaled gas transmission pipeline, an ultraviolet disinfection cavity, a gas transmission pipeline, an atomization pipeline, a medicine storage tank and a metering pump, the device comprises an ultrasonic atomizer, a first plate-shaped gas guide plate, a plasma disinfection cavity, a second plate-shaped gas guide plate, a third plate-shaped gas guide plate, an exhaust port, a wavy line gas guide plate, a wavy line gas guide plate, a mechanical arm, a medicine conveying pipeline, a discharge electrode, an insulating medium and a heating wire. According to the invention, the tuberculosis disinfection effect and treatment effect are improved, and the infection risk is reduced.

Description

Technical Field

[0001] The present invention relates to the technical field of pollutant disinfection treatment, and particularly to a treatment device and system for pollutants in a biomedical tuberculosis ward. Background Art

[0002] Tuberculosis bacteria are mainly transmitted through droplets. A large amount of bacteria are contained in the exhaled gas of patients. As a high-infection-risk environment, in a tuberculosis ward, medical staff come into frequent contact with patients. Manually wearing masks will increase the probability of cross-infection. An atomization treatment device can generate atomized particles with appropriate humidity, moisten the respiratory tract, dilute sputum, relieve the discomfort symptoms of patients, prevent the spread of bacteria in the ward, and protect the health of other patients and medical staff in the ward.

[0003] Chinese Patent Publication No.: CN107185024B discloses a saliva treatment device for a tuberculosis ward, including a cabinet body, a saliva treatment unit and a storage room. By connecting a saliva collection box to a disinfection room and a separation room respectively, after a patient spits saliva into the saliva collection box, the saliva collection box and the saliva therein can be immediately disinfected through the disinfection room, and the treated waste liquid can be separated in the separation room to separate the saliva and the disinfectant for subsequent discharge treatment; in addition, a saliva collection hopper is also provided on the cabinet body, and the saliva collection hopper can facilitate the use of bedridden patients. It can be seen that this solution only treats the saliva of patients, and cannot treat patients, making it difficult to improve the disinfection effect and treatment effect, and at the same time, it is difficult to reduce the infection risk. Summary of the Invention

[0004] Therefore, the present invention provides a treatment device for pollutants in a biomedical tuberculosis ward to overcome the problems of low tuberculosis disinfection effect and treatment effect and high infection risk in the prior art.

[0005] To achieve the above object, the present invention provides a treatment device for pollutants in a biomedical tuberculosis ward, and the treatment device includes:

[0006] A breathing mask, which is connected to a telescopic arm and is used for collecting the exhaled gas of a patient and performing atomization treatment on the patient;

[0007] A treatment system for pollutants in a biomedical tuberculosis ward, which is connected to the treatment device for pollutants in a biomedical tuberculosis ward and is used for controlling the treatment device for pollutants in a biomedical tuberculosis ward;

[0008] An exhaled gas transmission pipeline, which is connected to the breathing mask and an ultraviolet disinfection chamber and is used for transmitting the exhaled gas of a patient to the ultraviolet disinfection chamber;

[0009] An ultraviolet disinfection chamber, which is externally connected to an exhaled gas transmission pipeline, a gas transmission pipeline, and a plasma disinfection chamber, and internally provided with a left wavy gas deflector and a right wavy gas deflector for ultraviolet disinfection of the patient's exhaled gas;

[0010] A gas transmission pipeline, which is connected to the ultraviolet disinfection chamber and the plasma disinfection chamber, for transmitting the gas discharged from the plasma disinfection chamber that does not meet the emission standard to the ultraviolet disinfection chamber;

[0011] An atomization pipeline, which is connected to a breathing mask and an ultrasonic nebulizer, for transmitting the atomized drug in the ultrasonic nebulizer to the breathing mask;

[0012] A drug storage tank, which is connected to a metering pump for storing therapeutic drugs;

[0013] A metering pump, which is connected to the drug storage tank and connected to the ultrasonic nebulizer through a drug delivery pipeline, for transmitting the therapeutic drug from the drug storage tank to the ultrasonic nebulizer;

[0014] An ultrasonic nebulizer, which is connected to the metering pump through a drug delivery pipeline and connected to the breathing mask through an atomization pipeline, for atomizing the therapeutic drug to obtain atomized drug;

[0015] A first plate-shaped gas deflector, which is installed in the plasma disinfection chamber for guiding the patient's exhaled gas entering the plasma disinfection chamber;

[0016] A plasma disinfection chamber, which is connected to the ultraviolet disinfection chamber for plasma disinfection of the patient's exhaled gas;

[0017] A second plate-shaped gas deflector, which is installed in the plasma disinfection chamber for guiding the patient's exhaled gas entering the plasma disinfection chamber;

[0018] A third plate-shaped gas deflector, which is installed in the plasma disinfection chamber for guiding the patient's exhaled gas entering the plasma disinfection chamber;

[0019] An exhaust port, which is connected to the plasma disinfection chamber for discharging the gas meeting the emission standard;

[0020] A wavy gas deflector, which is installed in the ultraviolet disinfection chamber for guiding the patient's exhaled gas in the ultraviolet disinfection chamber;

[0021] A wavy gas deflector, which is installed in the ultraviolet disinfection chamber for guiding the patient's exhaled gas in the ultraviolet disinfection chamber;

[0022] A robotic arm, which is connected to the breathing mask for controlling the breathing mask to reach the patient's face;

[0023] A drug delivery pipeline, which is connected to a metering pump and an ultrasonic nebulizer and is used for transmitting therapeutic drugs;

[0024] A discharge electrode and an insulating medium, which are installed in an ultraviolet disinfection chamber and are used for generating cold plasma, preventing short circuits between electrodes, and regulating the electric field distribution;

[0025] A heating wire, which is installed in the ultrasonic nebulizer and is used for controlling the temperature of the atomized drug.

[0026] On the other hand, the present invention also provides a treatment system for pollutants in a biomedical tuberculosis ward, and the system includes:

[0027] An acquisition module, which acquires the operation data of the treatment device;

[0028] A disinfection control module, which is used for adjusting the plasma disinfection chamber according to the disinfection power of the plasma disinfection chamber, the preset minimum disinfection power, and the preset maximum disinfection power, and is also used for correcting the adjusted plasma disinfection chamber according to the pathogen concentration entering the plasma disinfection chamber, the preset minimum pathogen concentration, and the preset maximum pathogen concentration, and is also used for optimizing the process of correcting and adjusting the plasma disinfection chamber according to the patient's cough frequency and the preset patient cough frequency, and is also used for adjusting the metering pump according to the concentration of each therapeutic drug and the preset concentration of each therapeutic drug, and is also used for correcting the preset concentration of each therapeutic drug according to the patient's drug acceptance and the preset acceptance, and is also used for controlling the heating wire according to the atomized drug temperature, the preset minimum atomized drug temperature, and the preset maximum atomized drug temperature;

[0029] A treatment feedback module, which is used for outputting according to the pathogen concentration entering the plasma disinfection chamber after the preset treatment time and the preset pathogen concentration exhaled by the patient during recovery;

[0030] A gas emission module, which is used for controlling the exhaust port according to the pathogen concentration of the gas discharged from the plasma disinfection chamber and the preset pathogen concentration of the discharged gas.

[0031] Further, the disinfection control module compares the disinfection power P of the plasma disinfection chamber with the preset minimum disinfection power P1 and the preset maximum disinfection power P2, judges the magnitude of the disinfection power according to the comparison result, and adjusts the plasma disinfection chamber according to the judgment result, where:

[0032] P1 = 15W, P2 = 25W;

[0033] When P1 ≤ P ≤ P2, it is determined that the plasma disinfection power is normal, and the plasma disinfection chamber is not controlled;

[0034] When P < P1, it is determined that the plasma disinfection power is too low, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted. Among them, the original voltage is U0, and the adjusted voltage is Up0min, Up0min = U0 × (1 + e (P / P1) );

[0035] When P > P2, it is determined that the plasma disinfection power is too high, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted. Among them, the original voltage is U0, and the adjusted voltage is Up0max, Up0max = U0 × (1 - e (P / P1) ).

[0036] Furthermore, the disinfection control module compares the pathogen concentration L entering the plasma disinfection chamber with the preset minimum pathogen concentration L1 and the preset maximum pathogen concentration L2, judges the size of the pathogen concentration entering the plasma disinfection chamber according to the comparison result, and corrects the adjusted plasma disinfection chamber according to the judgment result, where:

[0037] L1 = 32CFU / m 3 , L2 = 128CFU / m 3 ;

[0038] When L1 ≤ L ≤ L2, it is determined that the size of the pathogen concentration entering the plasma disinfection chamber is normal, and the adjusted plasma disinfection chamber is not corrected;

[0039] When L < L1, it is determined that the pathogen concentration entering the plasma disinfection chamber is relatively low, and the adjusted plasma disinfection chamber is not corrected;

[0040] When L > L2, it is determined that the pathogen concentration entering the plasma disinfection chamber is relatively high. The method for correcting the adjusted plasma disinfection chamber is to increase the disinfection power P of the plasma disinfection chamber. The set disinfection power of the corrected plasma disinfection chamber is PL, PL = 0.82 + e 0.5×[(L-L0)+18] ×P.

[0041] Furthermore, the disinfection control module compares the patient's cough frequency K with the preset patient's cough frequency K0, judges the relationship between the patient's cough frequency and the pathogen concentration entering the plasma disinfection chamber according to the comparison result, and optimizes the process of correcting and adjusting the plasma disinfection chamber according to the judgment result, where:

[0042] When K ≤ K0, it is determined that the relationship between the patient's cough frequency and the pathogen concentration is that the patient's cough frequency is low frequency and does not affect the pathogen concentration entering the plasma disinfection chamber, and the process of correcting and adjusting the plasma disinfection chamber is not optimized;

[0043] When K > K0, it is determined that the relationship between the patient's cough frequency and the pathogen concentration is that the patient's cough frequency is high. The pathogen concentration entering the plasma disinfection chamber is increased, and the pathogen concentration L during the process of the plasma disinfection chamber after calibration and adjustment is optimized. The optimized pathogen concentration is set as Lk, and Lk = [0.77 + e 0.62×[(K-K0)+3] × L.

[0044] Furthermore, the disinfection control module compares each therapeutic drug concentration Y1, Y2, Y3, ……, Yn with the preset each therapeutic drug concentration Y01, Y02, Y03, …… Y0n, judges whether each therapeutic drug concentration meets the standard according to the comparison result, and adjusts the metering pump according to the judgment result, where:

[0045] When Y1 < Y10, it is determined that the concentration of this therapeutic drug is too low, and the volume Vy1 of this therapeutic drug delivered by the metering pump each time is adjusted to Vminy1, and Vminy1 = 1.5 × Vy1;

[0046] When Y1 = Y10, it is determined that the concentration of this therapeutic drug is appropriate, and the metering pump is not adjusted;

[0047] When Y1 > Y10, it is determined that the concentration of this therapeutic drug is too high, and the volume Vy1 of this therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy1, and Vmaxy1 = 0.5 × Vy1;

[0048] When Y2 < Y20, it is determined that the concentration of this therapeutic drug is too low, and the volume Vy2 of this therapeutic drug delivered by the metering pump each time is adjusted to Vminy2, and Vminy2 = 1.5 × Vy2;

[0049] When Y2 = Y20, it is determined that the concentration of this therapeutic drug is appropriate, and the metering pump is not adjusted; when Y2 > Y20, it is determined that the concentration of this therapeutic drug is too high, and the volume Vy2 of this therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy2, and Vmaxy2 = 0.5 × Vy2;

[0050] When Y3 < Y30, it is determined that the concentration of this therapeutic drug is too low, and the volume Vy3 of this therapeutic drug delivered by the metering pump each time is adjusted to Vminy3, and Vminy3 = 1.5 × Vy3;

[0051] When Y3 = Y30, it is determined that the concentration of this therapeutic drug is appropriate, and the metering pump is not adjusted; when Y3 > Y30, it is determined that the concentration of this therapeutic drug is too high, and the volume Vy3 of this therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy3, and Vmaxy3 = 0.5 × Vy3;

[0052] ……

[0053] When Yn < Yn0, it is determined that the concentration of the therapeutic drug is too low, and the volume Vyn of the therapeutic drug delivered by the metering pump each time is adjusted to Vminyn, where Vminyn = 1.5 × Vyn;

[0054] When Yn = Yn0, it is determined that the concentration of the therapeutic drug is appropriate, and the metering pump is not adjusted;

[0055] When Yn > Yn0, it is determined that the concentration of the therapeutic drug is too high, and the volume Vyn of the therapeutic drug delivered by the metering pump each time is adjusted to Vmaxyn, where Vmaxyn = 0.5 × Vyn.

[0056] Further, the disinfection control module compares the patient's drug acceptance J with the preset acceptance J0, judges the patient's treatment effect according to the comparison result, and corrects the preset concentrations of each therapeutic drug according to the judgment result, where:

[0057] When J ≥ J0, it is determined that the patient's treatment effect meets the standard, and the preset concentrations of each therapeutic drug are not corrected;

[0058] When J < J0, it is determined that the patient's treatment effect does not meet the standard, and the preset concentrations of each therapeutic drug are corrected. The corrected preset concentrations of each therapeutic drug are set as Yj01, Yj02, Yj03,..., Yj0n, and their calculation formulas are Yj01 = 1.68e J-J0 +2J + Y01, Yj02 = 1.68e J-J0 +2J + Y02, Yj03 = 1.68e J-J0 +2J + Y03,..., Yj0n = 1.68e J -J0 +2J + Y0n.

[0059] Further, the disinfection control module compares the temperature W of the atomized drug with the preset minimum atomized drug temperature W1 and the preset maximum atomized drug temperature W2, judges the credibility of the patient's drug acceptance according to the comparison result, and controls the heating wire according to the judgment result, where:

[0060] When W1 ≤ W ≤ W2, it is determined that the credibility of the patient's drug acceptance meets the standard, and the heating wire is not controlled;

[0061] When W < W1, it is determined that the credibility of the patient's drug acceptance does not meet the standard, and the heating wire is controlled to increase the temperature W of the atomized drug until it is determined that the credibility of the patient's drug acceptance meets the standard;

[0062] When W > W2, it is determined that the credibility of the patient's drug acceptance does not meet the standard, and the heating wire is controlled to decrease the temperature W of the atomized drug until it is determined that the credibility of the patient's drug acceptance meets the standard.

[0063] Further, the treatment feedback module compares the pathogen concentration L0 in the plasma disinfection chamber after the preset treatment time with the preset pathogen concentration L03 exhaled by the patient during recovery, judges the actual situation of the patient's treatment according to the comparison result, and outputs according to the judgment result, where:

[0064] When L = 0, it is determined that the actual situation of the patient's treatment is that the actual pathogen concentration exhaled by the patient is 0, and the patient has been successfully cured, and the output is to end the treatment;

[0065] When L ≤ L03, it is determined that the actual situation of the patient's treatment is that the actual pathogen concentration exhaled by the patient decreases, and the patient's condition improves, and the output is to maintain the treatment;

[0066] When L > L03, it is determined that the actual situation of the patient's treatment is that the actual pathogen concentration exhaled by the patient increases, and the patient's condition worsens. The output is to adjust the time for the patient to wear the breathing mask. The original time for the patient to wear the breathing mask is set as T0, and the adjusted time for wearing the breathing mask is T0`, and T0` = T0 + (L - L03) / L.

[0067] Further, the gas discharge module compares the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber with the preset pathogen concentration Lp0 of the discharged gas, judges whether the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard according to the comparison result, and controls the exhaust port according to the judgment result, where:

[0068] When Lp ≤ Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard, and the gas discharge module controls the exhaust port to open and discharges the gas discharged from the plasma disinfection chamber;

[0069] When Lp > Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber does not reach the emission standard, and the gas discharge module controls the exhaust port to close and re-transmits the gas discharged from the plasma disinfection chamber to the ultraviolet disinfection chamber for disinfection.

[0070] Compared with the prior art, the beneficial effects of the present invention are as follows. The device is applied in a tuberculosis ward. The device collects the exhaled gas of the patient through a breathing mask, a telescopic arm, and a gas transmission pipeline, and transmits it to an ultraviolet disinfection chamber. The left wavy gas deflector and the right wavy gas deflector in the ultraviolet disinfection chamber guide the flow of the exhaled gas of the patient, ensuring that the gas is fully exposed to ultraviolet light. At the same time, a discharge electrode and an insulating medium in the ultraviolet disinfection chamber generate low-temperature plasma to enhance the disinfection effect. The gas disinfected by the ultraviolet disinfection chamber enters the plasma disinfection chamber through the gas transmission pipeline. The first plate-shaped gas deflector, the second plate-shaped gas deflector, and the third plate-shaped gas deflector in the plasma disinfection chamber guide the flow of the gas disinfected by the ultraviolet disinfection chamber, ensuring that the gas disinfected by the ultraviolet disinfection chamber is fully exposed to the plasma for further disinfection. The gas meeting the emission standards after being disinfected by the ultraviolet disinfection chamber and the plasma disinfection chamber is discharged through the exhaust port. The device stores the therapeutic drug through a drug storage tank. At the same time, a metering pump transmits the therapeutic drug to an ultrasonic nebulizer through a drug delivery pipeline. A heating wire in the ultrasonic nebulizer regulates the temperature of the therapeutic drug to ensure the atomization effect. The ultrasonic nebulizer transmits the atomized therapeutic drug to the breathing mask through an atomization pipeline for atomization treatment of the patient. Among them, the device collects the exhaled gas of the patient through the breathing mask to ensure that the gas does not diffuse into the environment, and provides atomization treatment to deliver the drug to the patient. The device safely transmits the exhaled gas of the patient to the ultraviolet disinfection chamber through an exhaled gas transmission pipeline to prevent gas leakage. The device performs ultraviolet disinfection through the ultraviolet disinfection chamber, effectively killing pathogens in the exhaled gas, and through the wavy gas deflector to ensure that the gas is evenly exposed to ultraviolet light, improving the disinfection efficiency. The device performs plasma disinfection through the plasma disinfection chamber to further kill pathogens that cannot be completely treated by ultraviolet light, and through the plate-shaped gas deflector to ensure that the gas is evenly distributed in the chamber, improving the disinfection effect. The device atomizes the drug through the ultrasonic nebulizer, facilitating the patient's inhalation and improving the drug absorption efficiency. The device controls the drug delivery volume through the metering pump to ensure the treatment effect. The device stores the therapeutic drug through the drug storage tank to ensure the stability and effectiveness of the drug. The device discharges the qualified gas through the exhaust port to ensure environmental safety. The device generates low-temperature plasma through the discharge electrode and the insulating medium to enhance the ultraviolet disinfection effect and prevent electrode short-circuiting, ensuring the safe operation of the device. The device regulates the temperature of the drug through the heating wire to ensure the atomization effect and the patient's comfort.

[0071] In particular, the system collects the operation data of the processing device in real time through the acquisition module, providing data support for the disinfection control module, treatment feedback module, and gas emission module to ensure the dynamic monitoring of the disinfection and treatment processes. The system adjusts the disinfection power, corrects the disinfection power, optimizes the disinfection process, adjusts the delivery volume of the treatment drug by the metering pump, corrects the drug concentration setting, and regulates the working state of the heating wire through the disinfection control module to optimize the treatment process according to the specific conditions of the patient, improve the treatment effect, and thus ensure the maximization of the disinfection effect and treatment effect. The system evaluates the treatment effect and dynamically adjusts the treatment process through the treatment feedback module according to the change in the pathogen concentration to achieve precision medicine. The system ensures that the pathogen concentration in the discharged gas meets the safety standards through the gas emission module to avoid environmental pollution.

[0072] In particular, the acquisition module covers the data of disinfection, treatment, and emission, ensuring the comprehensive monitoring of the system operation and improving the operation efficiency.

[0073] In particular, the disinfection control module monitors the disinfection power P, compares it with the preset power range, and automatically adjusts the voltage of the discharge electrode to ensure that the disinfection process is carried out within a safe and effective power range, preventing insufficient disinfection effect or equipment damage. By monitoring the pathogen concentration L, it judges the disinfection demand and automatically adjusts the disinfection power to keep the indoor air quality within a safe range, thereby effectively controlling the infection risk. Combining with the patient's cough frequency K, it judges the impact of coughing on the pathogen concentration and further optimizes the disinfection process to cope with the potential increase in pathogen concentration and ensure the continuous effectiveness of the disinfection effect. By comparing the actual drug concentration with the preset standard concentration, it automatically adjusts the delivery volume of the metering pump to ensure that the drug concentration is always within the optimal range for treatment, improving the treatment effect. According to the patient's drug acceptance J, it adjusts the drug concentration to provide a personalized treatment plan to achieve the best treatment effect. By regulating the temperature of the atomized drug to ensure it is within the preset temperature range, it improves the drug acceptance and treatment comfort, contributing to improving the treatment quality and safety of the patient.

[0074] In particular, the treatment feedback module judges the patient's recovery situation by real-time monitoring of the pathogen concentration, ensures the treatment effectiveness, and adjusts the wearing time of the breathing mask to prevent the deterioration of the condition and ensure the safety of the patient.

[0075] In particular, the gas emission module ensures that only the gas meeting the safety standards is emitted by real-time monitoring of the pathogen concentration in the discharged gas, reducing the potential risks to the environment and human health. Description of the Drawings

[0076] Figure 1 It is a schematic structural diagram of the processing device for pollutants in the biomedical tuberculosis ward of this embodiment;

[0077] Figure 2 This is a schematic structural diagram of a treatment system for pollutants in a biomedical tuberculosis ward in this embodiment. Detailed implementation manners

[0078] In order to make the objectives and advantages of the present invention clearer, the present invention will be further described below in conjunction with embodiments; it should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0079] The preferred implementation manners of the present invention will be described below with reference to the accompanying drawings. Those skilled in the art should understand that these implementation manners are only used to explain the technical principles of the present invention and do not limit the protection scope of the present invention.

[0080] It should be noted that in the description of the present invention, the terms indicating directions or positional relationships such as "upper", "lower", "left", "right", "inner", "outer", etc. are based on the directions or positional relationships shown in the drawings. This is only for the convenience of description and does not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as a limitation to the present invention.

[0081] In addition, it should also be noted that in the description of the present invention, unless otherwise clearly specified and limited, the terms "installation", "connection", and "coupling" should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be directly connected or indirectly connected through an intermediate medium, and it can be the communication inside two elements. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood according to specific situations.

[0082] Please refer to Figure 1 As shown, it is a schematic structural diagram of a treatment device for pollutants in a biomedical tuberculosis ward in this example. The treatment device includes:

[0083] A breathing mask 1, which is connected to a telescopic arm 17 and is used to collect the exhaled gas of the patient and perform atomization treatment on the patient;

[0084] A treatment system 2 for pollutants in a biomedical tuberculosis ward, which is connected to the treatment device for pollutants in a biomedical tuberculosis ward and is used to control the treatment device for pollutants in a biomedical tuberculosis ward;

[0085] An exhaled gas transmission pipeline 3, which is connected to the breathing mask 1 and an ultraviolet disinfection chamber 4 and is used to transmit the exhaled gas of the patient to the ultraviolet disinfection chamber 4;

[0086] The ultraviolet disinfection chamber 4 is externally connected to the exhaled gas transmission pipeline 3, the gas transmission pipeline 5, and the plasma disinfection chamber 11. Inside it, there are a left wavy gas deflector 15 and a right wavy gas deflector 16 for ultraviolet disinfection of the patient's exhaled gas.

[0087] The gas transmission pipeline 5 is connected to the ultraviolet disinfection chamber 4 and the plasma disinfection chamber 11, and is used to transmit the exhaust gas discharged from the plasma disinfection chamber that does not meet the emission standard to the ultraviolet disinfection chamber 4.

[0088] The atomization pipeline 6 is connected to the breathing mask 1 and the ultrasonic nebulizer 9, and is used to transmit the atomized drug in the ultrasonic nebulizer 9 to the breathing mask 1.

[0089] The drug storage tank 7 is connected to the metering pump 8 and is used to store the therapeutic drug.

[0090] The metering pump 8 is connected to the drug storage tank 7 and is connected to the ultrasonic nebulizer 9 through the drug delivery pipeline 18, and is used to transmit the therapeutic drug from the drug storage tank 7 to the ultrasonic nebulizer 9.

[0091] The ultrasonic nebulizer 9 is connected to the metering pump 8 through the drug delivery pipeline 18 and is connected to the breathing mask 1 through the atomization pipeline 6, and is used to atomize the therapeutic drug to obtain the atomized drug.

[0092] The first plate-shaped gas deflector 10 is installed inside the plasma disinfection chamber 11 and is used to divert the patient's exhaled gas entering the plasma disinfection chamber 11.

[0093] The plasma disinfection chamber 11 is connected to the ultraviolet disinfection chamber 4 and is used to perform plasma disinfection on the patient's exhaled gas.

[0094] The second plate-shaped gas deflector 12 is installed inside the plasma disinfection chamber 11 and is used to divert the patient's exhaled gas entering the plasma disinfection chamber 11.

[0095] The third plate-shaped gas deflector 13 is installed inside the plasma disinfection chamber 11 and is used to divert the patient's exhaled gas entering the plasma disinfection chamber 11.

[0096] The exhaust port 14 is connected to the plasma disinfection chamber 11 and is used to discharge the gas that meets the emission standard.

[0097] The wavy gas deflector 15 is installed inside the ultraviolet disinfection chamber 4 and is used to divert the patient's exhaled gas inside the ultraviolet disinfection chamber 4.

[0098] The wavy gas deflector 16 is installed inside the ultraviolet disinfection chamber 4 and is used to divert the patient's exhaled gas inside the ultraviolet disinfection chamber 4.

[0099] The robotic arm 17, which is connected to the breathing mask 1 and is used to control the breathing mask 1 to reach the patient's face;

[0100] The drug delivery pipeline 18, which is connected to the metering pump 8 and the ultrasonic nebulizer 9 and is used to transmit the therapeutic drug;

[0101] The discharge electrode and the insulating medium 19, which are installed in the ultraviolet disinfection chamber 4 and are used to generate cold plasma, prevent short circuits between the electrodes, and adjust the electric field distribution;

[0102] The heating wire 20, which is installed in the ultrasonic nebulizer 9 and is used to control the temperature of the atomized drug.

[0103] Specifically, the device is applied in a tuberculosis ward. The device collects the exhaled gas of the patient through a breathing mask 1, a telescopic arm 17, and a gas transmission pipeline 3, and transmits it to an ultraviolet disinfection chamber 4. The left wavy gas guide plate 15 and the right wavy gas guide plate 16 in the ultraviolet disinfection chamber 4 guide the flow of the exhaled gas of the patient, ensuring that the gas is fully exposed to ultraviolet light. At the same time, a discharge electrode and an insulating medium 19 in the ultraviolet disinfection chamber 4 generate low-temperature plasma to enhance the disinfection effect. The gas disinfected by the ultraviolet disinfection chamber 4 enters a plasma disinfection chamber 11 through a gas transmission pipeline 5. The first plate-shaped gas guide plate 10, the second plate-shaped gas guide plate 12, and the third plate-shaped gas guide plate 13 in the plasma disinfection chamber 11 guide the flow of the gas disinfected by the ultraviolet disinfection chamber 4, ensuring that the gas disinfected by the ultraviolet disinfection chamber 4 is fully exposed to the plasma for further disinfection. The gas that meets the emission standards after being disinfected by the ultraviolet disinfection chamber 4 and the plasma disinfection chamber 11 is discharged through an exhaust port 14. The device stores therapeutic drugs through a drug storage tank 7. At the same time, a metering pump 8 transmits the therapeutic drugs to an ultrasonic nebulizer 9 through a drug delivery pipeline 18. A heating wire 20 in the ultrasonic nebulizer 9 regulates the temperature of the therapeutic drugs to ensure the atomization effect. The ultrasonic nebulizer 9 transmits the atomized therapeutic drugs to the breathing mask 1 through an atomization pipeline 6 for atomization treatment of the patient. Among them, the device collects the exhaled gas of the patient through the breathing mask 1 to ensure that the gas does not diffuse into the environment, and provides atomization treatment to deliver drugs to the patient. The device safely transmits the exhaled gas of the patient to the ultraviolet disinfection chamber 4 through an exhaled gas transmission pipeline to prevent gas leakage. The device performs ultraviolet disinfection through the ultraviolet disinfection chamber 4 to effectively kill pathogens in the exhaled gas, and ensures that the gas is evenly exposed to ultraviolet light through the wavy gas guide plates 15 and 16 to improve the disinfection efficiency. The device performs plasma disinfection through the plasma disinfection chamber 11 to further kill pathogens that cannot be completely treated by ultraviolet light, and ensures that the gas is evenly distributed in the chamber through the plate-shaped gas guide plates 10, 12, and 13 to improve the disinfection effect. The device atomizes the drugs through the ultrasonic nebulizer 9 to facilitate the patient's inhalation and improve the drug absorption efficiency. The device controls the drug delivery volume through the metering pump 8 to ensure the treatment effect. The device stores therapeutic drugs through the drug storage tank 7 to ensure the stability and effectiveness of the drugs. The device discharges the qualified gas through the exhaust port 14 to ensure environmental safety. The device generates low-temperature plasma through the discharge electrode and the insulating medium 19 to enhance the ultraviolet disinfection effect and prevent electrode short-circuiting to ensure the safe operation of the device. The device regulates the temperature of the drugs through the heating wire 20 to ensure the atomization effect and the patient's comfort.

[0104] Specifically, a preset number of high-intensity ultraviolet lamps with an emission wavelength of 253.7 nm are installed in the ultraviolet disinfection chamber 4. At the same time, a wavy gas deflector 15 and a wavy gas deflector 16 are arranged in the ultraviolet disinfection chamber 4, so that the exhaled gas of the patient forms a target flow path in the ultraviolet disinfection chamber 4.

[0105] Specifically, the high-intensity ultraviolet lamp refers to a light source that can emit high-intensity ultraviolet radiation for disinfection, sterilization, and photochemical reactions. In this embodiment, the specific value of the preset number is not limited, and those skilled in the relevant art can freely set it according to actual needs, as long as it meets the requirement of ultraviolet disinfection of the exhaled gas of the patient. For example, the preset number can be set to 6.

[0106] Specifically, the capacity L of the drug storage tank 7 ranges from 50 ml to 200 ml, and a transparent observation window is provided.

[0107] Specifically, the capacity refers to the volume of the liquid medicine that the drug storage tank 7 can hold. The transparent observation window refers to an observation window made of transparent and translucent materials, which allows users to observe the internal liquid medicine situation of the drug storage tank 7 without opening it.

[0108] Specifically, a voltage sensor is further provided in the plasma disinfection chamber 11. A nucleic acid aptamer of Mycobacterium tuberculosis is arranged on the surface of the voltage sensor. When the nucleic acid aptamer of Mycobacterium tuberculosis binds to Mycobacterium tuberculosis, the voltage on the surface of the voltage sensor changes.

[0109] Specifically, the voltage sensor refers to an electronic device that detects and measures the voltage signal in a circuit and converts it into a readable output. The nucleic acid aptamer of Mycobacterium tuberculosis refers to a specific target that can specifically recognize and bind to Mycobacterium tuberculosis. Mycobacterium tuberculosis refers to the pathogenic bacterium that causes tuberculosis.

[0110] Specifically, among the discharge electrode and the insulating medium 19, the discharge electrode is made of a metal material molybdenum alloy. And an insulating medium is arranged around the discharge electrode.

[0111] Specifically, the molybdenum alloy refers to an alloy material mainly composed of molybdenum and added with metal elements such as titanium, zirconium, hafnium, and rhenium. The specific number of the insulating medium is not limited in this embodiment, and those skilled in the relevant art can freely set it according to actual needs, as long as it meets the requirement of plasma disinfection of the exhaled gas of the patient. For example, the number of the insulating medium can be set to 8.

[0112] Please refer to Figure 2 As shown, it is a schematic structural diagram of the processing system for pollutants in a biomedical tuberculosis ward in this embodiment. The system includes:

[0113] A collection module for collecting the operation data of the processing device;

[0114] A disinfection control module for adjusting the plasma disinfection chamber according to the disinfection power of the plasma disinfection chamber, the preset minimum disinfection power and the preset maximum disinfection power, and for correcting the adjusted plasma disinfection chamber according to the pathogen concentration entering the plasma disinfection chamber, the preset minimum pathogen concentration and the preset maximum pathogen concentration, and for optimizing the process of correcting and adjusting the plasma disinfection chamber according to the patient's cough frequency and the preset patient cough frequency, and for adjusting the metering pump according to the concentration of each therapeutic drug and the preset concentration of each therapeutic drug, and for correcting the preset concentration of each therapeutic drug according to the patient's drug acceptance and the preset acceptance, and for controlling the heating wire according to the temperature of the atomized drug, the preset minimum atomized drug temperature and the preset maximum atomized drug temperature. The disinfection control module is connected to the collection module;

[0115] A treatment feedback module for outputting according to the pathogen concentration entering the plasma disinfection chamber after the preset treatment time and the preset pathogen concentration exhaled by the patient during recovery. The treatment feedback module is connected to the disinfection control module and the collection module;

[0116] A gas discharge module for controlling the exhaust port according to the pathogen concentration of the gas discharged from the plasma disinfection chamber and the preset pathogen concentration of the discharged gas. The gas discharge module is connected to the disinfection control module and the collection module.

[0117] Specifically, the system is applied to the processing device for the pollutants in the biomedical tuberculosis ward. The system collects the operation data of the processing device through the collection module, and controls the processing device for the pollutants in the biomedical tuberculosis ward through the disinfection control module. At the same time, the treatment feedback module outputs the actual treatment effect of the patient in real time. Finally, the system controls the exhaust port through the gas discharge module to reduce the infection risk. In particular, the system collects the operation data of the processing device in real time through the collection module, provides data support for the disinfection control module, the treatment feedback module and the gas discharge module, and ensures the dynamic monitoring of the disinfection and treatment processes. The system adjusts the disinfection power, corrects the disinfection power, optimizes the disinfection process, adjusts the delivery volume of the therapeutic drug by the metering pump, corrects the drug concentration setting, and controls the working state of the heating wire through the disinfection control module to optimize the treatment process according to the specific conditions of the patient, improve the treatment effect, and thus ensure the maximization of the disinfection effect and the treatment effect. The system evaluates the treatment effect according to the change of the pathogen concentration through the treatment feedback module, dynamically adjusts the treatment process, and realizes precision medicine. The system ensures that the pathogen concentration in the discharged gas meets the safety standards through the gas discharge module and avoids environmental pollution.

[0118] Specifically, the acquisition module collects the operation data of the processing device. Among them, the operation data of the processing device includes the disinfection power of the plasma disinfection chamber, the concentration of pathogens entering the plasma disinfection chamber, the patient's cough frequency, the concentration of each therapeutic drug, the patient's drug acceptance, the temperature of the atomized drug, the concentration of pathogens entering the plasma disinfection chamber after the preset treatment time, and the concentration of pathogens in the gas discharged from the plasma disinfection chamber.

[0119] Specifically, this embodiment does not limit the acquisition method of the operation data of the processing device. Those skilled in the relevant art can freely set it according to actual needs, as long as it meets the requirement of collecting the operation data of the processing device. For example, it can be set to collect the operation data of the processing device through sensors. The disinfection power of the plasma disinfection chamber refers to the electric power consumed by the plasma disinfection chamber during operation. The concentration of pathogens entering the plasma disinfection chamber refers to the concentration of pathogens such as Mycobacterium tuberculosis in the patient's exhaled gas entering the plasma disinfection chamber. The patient's cough frequency refers to the number of coughs per unit time of the patient. The concentration of each therapeutic drug refers to the concentration of various therapeutic drugs in the atomized drug. The patient's drug acceptance refers to the patient's tolerance to the drug and the feedback on the treatment effect. The temperature of the atomized drug refers to the current temperature of the atomized drug. The concentration of pathogens entering the plasma disinfection chamber after the preset treatment time refers to the concentration of pathogens in the patient's exhaled gas entering the plasma disinfection chamber after the preset treatment time. The concentration of pathogens in the gas discharged from the plasma disinfection chamber refers to the concentration of pathogens in the gas treated by plasma disinfection. The preset treatment time refers to the preset treatment cycle time. This embodiment does not limit the specific value of the preset treatment time. Those skilled in the relevant art can freely set it according to actual needs, as long as it meets the requirement of judging the actual treatment effect of the patient. For example, the preset treatment time can be set to 3 days.

[0120] Specifically, the acquisition module covers the data of disinfection, treatment, and emission, ensuring comprehensive monitoring of the system operation and improving the operation efficiency.

[0121] Specifically, the disinfection control module compares the disinfection power P of the plasma disinfection chamber with the preset minimum disinfection power P1 and the preset maximum disinfection power P2, judges the size of the disinfection power according to the comparison result, and adjusts the plasma disinfection chamber according to the judgment result, where:

[0122] P1 = 15W, P2 = 25W;

[0123] When P1 ≤ P ≤ P2, it is determined that the plasma disinfection power is normal, and the plasma disinfection chamber is not controlled;

[0124] When P < P1, it is determined that the plasma disinfection power is too low, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted. Among them, the original voltage is U0, and the adjusted voltage is Up0min, Up0min = U0×(1 + e (P / P1) );

[0125] When P > P2, it is determined that the plasma disinfection power is too high, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted. Among them, the original voltage is U0, and the adjusted voltage is Up0max, Up0max = U0×(1 - e (P / P1) );

[0126] The disinfection control module compares the pathogen concentration L entering the plasma disinfection chamber with the preset minimum pathogen concentration L1 and the preset maximum pathogen concentration L2, judges the size of the pathogen concentration entering the plasma disinfection chamber according to the comparison result, and corrects the adjusted plasma disinfection chamber according to the judgment result, where:

[0127] L1 = 32CFU / m 3 and L2 = 128CFU / m 3 ;

[0128] When L1 ≤ L ≤ L2, it is determined that the size of the pathogen concentration entering the plasma disinfection chamber is normal, and the adjusted plasma disinfection chamber is not corrected;

[0129] When L < L1, it is determined that the pathogen concentration entering the plasma disinfection chamber is low, and the adjusted plasma disinfection chamber is not corrected;

[0130] When L > L2, it is determined that the pathogen concentration entering the plasma disinfection chamber is high. The method of correcting the adjusted plasma disinfection chamber is to increase the disinfection power P of the plasma disinfection chamber. The set disinfection power of the corrected plasma disinfection chamber is PL, PL = 0.82 + e 0.5×[(L-L0)+18] ×P;

[0131] The disinfection control module compares the patient's cough frequency K with the preset patient's cough frequency K0, judges the relationship between the patient's cough frequency and the pathogen concentration entering the plasma disinfection chamber according to the comparison result, and optimizes the process of correcting the adjusted plasma disinfection chamber according to the judgment result, where:

[0132] When K ≤ K0, it is determined that the relationship between the patient's cough frequency and the pathogen concentration is that the patient's cough frequency is low frequency, which does not affect the pathogen concentration entering the plasma disinfection chamber, and the process of correcting the adjusted plasma disinfection chamber is not optimized;

[0133] When K > K0, it is determined that the relationship between the patient's cough frequency and the pathogen concentration is that the patient's cough frequency is high. Increase the pathogen concentration entering the plasma disinfection chamber, optimize the pathogen concentration L during the process of the adjusted plasma disinfection chamber, and set the optimized pathogen concentration as Lk, where Lk = [0.77 + e 0.62×[(K-K0)+3] × L;

[0134] The disinfection control module compares each therapeutic drug concentration Y1, Y2, Y3, ……, Yn with the preset each therapeutic drug concentration Y01, Y02, Y03, …… Y0n, judges whether each therapeutic drug concentration meets the standard according to the comparison result, and adjusts the metering pump according to the judgment result, where:

[0135] When Y1 < Y10, it is determined that the concentration of this therapeutic drug is too low, and the volume Vy1 of this therapeutic drug delivered by the metering pump each time is adjusted to Vminy1, where Vminy1 = 1.5 × Vy1;

[0136] When Y1 = Y10, it is determined that the concentration of this therapeutic drug is appropriate and the metering pump is not adjusted;

[0137] When Y1 > Y10, it is determined that the concentration of this therapeutic drug is too high, and the volume Vy1 of this therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy1, where Vmaxy1 = 0.5 × Vy1;

[0138] When Y2 < Y20, it is determined that the concentration of this therapeutic drug is too low, and the volume Vy2 of this therapeutic drug delivered by the metering pump each time is adjusted to Vminy2, where Vminy2 = 1.5 × Vy2;

[0139] When Y2 = Y20, it is determined that the concentration of this therapeutic drug is appropriate and the metering pump is not adjusted; when Y2 > Y20, it is determined that the concentration of this therapeutic drug is too high, and the volume Vy2 of this therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy2, where Vmaxy2 = 0.5 × Vy2;

[0140] When Y3 < Y30, it is determined that the concentration of this therapeutic drug is too low, and the volume Vy3 of this therapeutic drug delivered by the metering pump each time is adjusted to Vminy3, where Vminy3 = 1.5 × Vy3;

[0141] When Y3 = Y30, it is determined that the concentration of this therapeutic drug is appropriate and the metering pump is not adjusted; when Y3 > Y30, it is determined that the concentration of this therapeutic drug is too high, and the volume Vy3 of this therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy3, where Vmaxy3 = 0.5 × Vy3;

[0142] ……

[0143] When Yn < Yn0, it is determined that the concentration of the therapeutic drug is too low, and the volume Vyn of the therapeutic drug delivered by the metering pump each time is adjusted to Vminyn, where Vminyn = 1.5 × Vyn;

[0144] When Yn = Yn0, it is determined that the concentration of the therapeutic drug is appropriate, and the metering pump is not adjusted;

[0145] When Yn > Yn0, it is determined that the concentration of the therapeutic drug is too high, and the volume Vyn of the therapeutic drug delivered by the metering pump each time is adjusted to Vmaxyn, where Vmaxyn = 0.5 × Vyn;

[0146] The disinfection control module compares the patient's drug acceptance J with the preset acceptance J0, judges the patient's treatment effect according to the comparison result, and corrects the preset concentrations of each therapeutic drug according to the judgment result, where:

[0147] When J ≥ J0, it is determined that the patient's treatment effect reaches the standard, and the preset concentrations of each therapeutic drug are not corrected;

[0148] When J < J0, it is determined that the patient's treatment effect does not reach the standard, and the preset concentrations of each therapeutic drug are corrected. The corrected preset concentrations of each therapeutic drug are set as Yj01, Yj02, Yj03,..., Yj0n, and their calculation formulas are Yj01 = 1.68e J-J0 +2J + Y01, Yj02 = 1.68e J-J0 +2J + Y02, Yj03 = 1.68e J-J0 +2J + Y03,..., Yj0n = 1.68e J -J0 +2J + Y0n;

[0149] The disinfection control module compares the temperature W of the atomized drug with the preset minimum atomized drug temperature W1 and the preset maximum atomized drug temperature W2, judges the credibility of the patient's drug acceptance according to the comparison result, and controls the heating wire according to the judgment result, where:

[0150] When W1 ≤ W ≤ W2, it is determined that the credibility of the patient's drug acceptance reaches the standard, and the heating wire is not controlled;

[0151] When W < W1, it is determined that the credibility of the patient's drug acceptance does not reach the standard, and the heating wire is controlled to increase the temperature W of the atomized drug until it is determined that the credibility of the patient's drug acceptance reaches the standard;

[0152] When W > W2, it is determined that the credibility of the patient's drug acceptance does not reach the standard, and the heating wire is controlled to decrease the temperature W of the atomized drug until it is determined that the credibility of the patient's drug acceptance reaches the standard.

[0153] Specifically, the preset minimum disinfection power P1 refers to the minimum power value set during the plasma disinfection process. The preset maximum disinfection power P2 refers to the maximum power value set during the plasma disinfection process. The original voltage U0 refers to the reference voltage value of the discharge electrode in the plasma disinfection chamber before adjustment. In this embodiment, the specific value of the original voltage U0 is not limited. For example, the original voltage U0 can be set to 36V. The preset minimum pathogen concentration L1 refers to the lowest value of the pathogen concentration that can be accepted in the air entering the plasma disinfection chamber. The preset maximum pathogen concentration L2 refers to the highest value of the pathogen concentration that can be accepted in the air entering the plasma disinfection chamber. The preset patient cough frequency K0 refers to the reference value of the patient's cough frequency. In this embodiment, the specific value of the cough frequency K0 is not limited. For example, the cough frequency K0 can be set to 3 times per minute. The preset concentrations of various therapeutic drugs Y01, Y02, Y03, …… Y0n refer to the standard concentration values of each therapeutic drug. In this embodiment, the specific types and values of the preset concentrations of various therapeutic drugs Y01, Y02, Y03, …… Y0n are not limited. For example, isoniazid can be set as Y01, and its standard concentration value is 50 - 200mg / mL; rifampicin can be set as Y02, and its standard concentration value is 10 - 100mg / mL; streptomycin can be set as Y03, and its standard concentration value is 25 - 100mg / mL; ……, ambroxol can be set as Y0n, and its standard concentration value is 15 - 30mg / mL. The preset acceptance J0 refers to the reference acceptance of the patient for drug treatment. In this embodiment, the specific value of the preset acceptance J0 is not limited. For example, the preset acceptance J0 can be set to 0.65. The preset minimum atomized drug temperature W1 refers to the lower limit of the temperature of the atomized drug. In this embodiment, the specific value of the preset minimum atomized drug temperature W1 is not limited. For example, the preset minimum atomized drug temperature W1 can be set to 35°C. The preset maximum atomized drug temperature W2 refers to the upper limit of the temperature of the atomized drug. In this embodiment, the specific value of the preset maximum atomized drug temperature W2 is not limited. For example, the preset maximum atomized drug temperature W2 can be set to 38°C.

[0154] Specifically, the disinfection control module monitors the disinfection power P, compares it with a preset power range, and automatically adjusts the voltage of the discharge electrode to ensure that the disinfection process is carried out within a safe and effective power range, preventing insufficient disinfection effect or equipment damage. By monitoring the pathogen concentration L, it judges the disinfection requirement and automatically adjusts the disinfection power to keep the indoor air quality within a safe range, thereby effectively controlling the infection risk. Combining with the patient's cough frequency K, it judges the impact of coughing on the pathogen concentration, further optimizing the disinfection process to cope with potential increases in pathogen concentration and ensuring the continuous effectiveness of the disinfection effect. By comparing the actual drug concentration with the preset standard concentration, it automatically adjusts the delivery volume of the metering pump to ensure that the drug concentration is always within the optimal range for treatment, improving the treatment effect. According to the patient's drug acceptance J, it adjusts the drug concentration to provide a personalized treatment plan to achieve the best treatment effect. By adjusting the temperature of the atomized drug to ensure it is within a preset temperature range, it improves the drug acceptance and treatment comfort, contributing to improving the patient's treatment quality and safety.

[0155] Specifically, the treatment feedback module compares the pathogen concentration L0 entering the plasma disinfection chamber after a preset treatment time with the preset pathogen concentration L03 exhaled by the patient during recovery, judges the actual situation of the patient's treatment according to the comparison result, and outputs according to the judgment result, where:

[0156] When L = 0, it is determined that the actual situation of the patient's treatment is that the actual pathogen concentration exhaled by the patient is 0 and the patient has been successfully cured, and the output is to end the treatment;

[0157] When L ≤ L03, it is determined that the actual situation of the patient's treatment is that the actual pathogen concentration exhaled by the patient decreases and the patient's condition improves, and the output is to maintain the treatment;

[0158] When L > L03, it is determined that the actual situation of the patient's treatment is that the actual pathogen concentration exhaled by the patient increases and the patient's condition worsens, and the output is to adjust the time for the patient to wear the breathing mask. The original time for the patient to wear the breathing mask is set as T0, and the adjusted time for wearing the breathing mask is T0`, where T0` = T0 + (L - L03) / L.

[0159] Specifically, the preset patient recovery exhaled pathogen concentration L03 refers to the target value of the expected pathogen concentration in the exhaled air of the patient during the patient's recovery process. In this embodiment, the specific value of the preset patient recovery exhaled pathogen concentration L03 is not limited, and those skilled in the relevant art can freely set it according to actual needs, as long as it meets the requirement of judging the actual situation of the patient's treatment. For example, the preset patient recovery exhaled pathogen concentration L03 = 16 CFU / m3 can be set. The original wearing time of the breathing mask for the patient refers to the standard wearing time length of the breathing mask set for the patient at the beginning of the treatment. In this embodiment, the specific value of the original wearing time of the breathing mask for the patient is not limited. For example, the original wearing time of the breathing mask for the patient can be set to 8 hours per day.

[0160] Specifically, the treatment feedback module judges the patient's recovery situation by real-time monitoring of the pathogen concentration, ensures the treatment effectiveness, adjusts the wearing time of the breathing mask, prevents the deterioration of the condition, and guarantees the safety of the patient.

[0161] Specifically, the gas discharge module compares the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber with the preset discharged gas pathogen concentration Lp0, judges whether the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard according to the comparison result, and controls the exhaust port according to the judgment result, where:

[0162] When Lp ≤ Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard, and the gas discharge module controls the exhaust port to open to discharge the gas discharged from the plasma disinfection chamber;

[0163] When Lp > Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber does not reach the emission standard, and the gas discharge module controls the exhaust port to close and re-transmits the gas discharged from the plasma disinfection chamber to the ultraviolet disinfection chamber for disinfection.

[0164] Specifically, the preset discharged gas pathogen concentration Lp0 refers to the concentration value of the pathogens allowed in the gas discharged from the plasma disinfection chamber. In this embodiment, the specific value of the preset discharged gas pathogen concentration Lp0 is not limited, and those skilled in the relevant art can freely set it according to actual needs, as long as it meets the requirement of judging whether the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard. For example, the preset discharged gas pathogen concentration Lp0 = 0.01 CFU / m3 can be set.

[0165] Specifically, the gas discharge module ensures that only the gas meeting the safety standards is discharged by real-time monitoring of the pathogen concentration of the discharged gas, reducing the potential risks to the environment and human health.

[0166] So far, the technical solution of the present invention has been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it is easy for those skilled in the art to understand that the protection scope of the present invention is obviously not limited to these specific embodiments. Without departing from the principle of the present invention, those skilled in the art can make equivalent changes or substitutions to the relevant technical features, and the technical solutions after these changes or substitutions will fall within the protection scope of the present invention.

Claims

1. A device for treating pollutants in a biomedical tuberculosis ward, characterized in that: The processing device comprises: A breathing mask connected to a telescopic arm for collecting the patient's exhaled gas and performing aerosol therapy on the patient; A system for treating pollutants in a biomedical tuberculosis ward, which is connected to a device for treating pollutants in a biomedical tuberculosis ward and is used to control the device for treating pollutants in a biomedical tuberculosis ward; An exhaled gas transmission pipeline, which is connected to the breathing mask and the ultraviolet disinfection chamber, and is used to transmit the patient's exhaled gas to the ultraviolet disinfection chamber; The ultraviolet disinfection chamber is connected to the exhaled gas transmission pipeline, the gas transmission pipeline and the plasma disinfection chamber on the outside, and is provided with a left wavy gas guide plate and a right wavy gas guide plate on the inside for ultraviolet disinfection of the patient's exhaled gas; A gas transmission pipeline, which is connected to the ultraviolet disinfection chamber and the plasma disinfection chamber, and is used to transmit the exhaust gas of the plasma disinfection chamber that does not meet the emission standards to the ultraviolet disinfection chamber; an atomization pipeline, which is connected to the breathing mask and the ultrasonic atomizer, and is used to transmit the atomized medicine in the ultrasonic atomizer to the breathing mask; A drug storage tank connected to a metering pump for storing therapeutic drugs; A metering pump connected to the drug storage tank and connected to the ultrasonic nebulizer through a drug delivery pipeline, and used for transferring the therapeutic drug from the drug storage tank to the ultrasonic nebulizer; An ultrasonic nebulizer, which is connected to a metering pump via a drug delivery pipeline and to a breathing mask via an atomization pipeline, is used to atomize the therapeutic drug to obtain atomized drug; A first plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber; A plasma disinfection chamber, connected to the ultraviolet disinfection chamber, is used to perform plasma disinfection on the patient's exhaled gas; A second plate-shaped gas guide plate is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber; A third plate-shaped gas guide plate is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber; An exhaust port, which is connected to the plasma disinfection chamber and is used to discharge gas that meets the emission standards; A wavy gas deflector is installed in the ultraviolet disinfection chamber and is used to drain the exhaled gas of the patient in the ultraviolet disinfection chamber; A wavy gas deflector is installed in the ultraviolet disinfection chamber and is used to drain the exhaled gas of the patient in the ultraviolet disinfection chamber; A robotic arm connected to the breathing mask and used to control the breathing mask to reach the patient's face; a drug delivery pipeline connected to a metering pump and an ultrasonic nebulizer for delivering therapeutic drugs; Discharge electrodes and insulating media, which are installed in the ultraviolet disinfection chamber, are used to generate low-temperature plasma, prevent short circuits between electrodes, and adjust electric field distribution; The heating wire is installed in the ultrasonic nebulizer and is used to regulate the temperature of the nebulized medicine.

2. A treatment system applied to the device for treating pollutants in a biomedical tuberculosis ward as claimed in claim 1, characterized in that: The system comprises: A collection module collects the operation data of the processing device; A disinfection control module, for adjusting the plasma disinfection chamber according to the disinfection power of the plasma disinfection chamber and a preset minimum disinfection power and a preset maximum disinfection power, for correcting the adjusted plasma disinfection chamber according to the concentration of pathogens entering the plasma disinfection chamber and a preset minimum pathogen concentration and a preset maximum pathogen concentration, for optimizing the process of the corrected and adjusted plasma disinfection chamber according to the cough frequency of the patient and a preset patient cough frequency, for adjusting the metering pump according to the concentration of each therapeutic drug and a preset concentration of each therapeutic drug, for correcting the preset concentration of each therapeutic drug according to the patient's drug acceptance and a preset acceptance, and for regulating the heating wire according to the atomized drug temperature and a preset minimum atomized drug temperature and a preset maximum atomized drug temperature; A treatment feedback module is used to output the concentration of pathogens entering the plasma disinfection chamber after a preset treatment time and the concentration of pathogens recovered by the patient's exhaled blood; The gas exhaust module is used to control the exhaust port according to the pathogen concentration of the exhaust gas from the plasma disinfection chamber and the preset pathogen concentration of the exhaust gas.

3. The system for treating pollutants in a biomedical tuberculosis ward according to claim 2, characterized in that: The disinfection control module compares the disinfection power P of the plasma disinfection chamber with the preset minimum disinfection power P1 and the preset maximum disinfection power P2, judges the size of the disinfection power according to the comparison result, and adjusts the plasma disinfection chamber according to the judgment result, wherein: P1 = 15W, P2 = 25W; When P1≤P≤P2, it is determined that the plasma disinfection power is normal, and the plasma disinfection chamber is not controlled; When P<P1, it is determined that the plasma disinfection power is too low, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0min, Up0min=U0×(1+e (P / P1) ); When P>P2, it is determined that the plasma disinfection power is too high, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0max, Up0max=U0×(1-e (P / P1) ).

4. The system for treating pollutants in a biomedical tuberculosis ward according to claim 3, characterized in that: The disinfection control module compares the pathogen concentration L entering the plasma disinfection chamber with the preset minimum pathogen concentration L1 and the preset maximum pathogen concentration L2, judges the concentration of the pathogen entering the plasma disinfection chamber according to the comparison result, and calibrates the adjusted plasma disinfection chamber according to the judgment result, wherein: L1=32CFU / m 3 ,L2=128CFU / m 3 ; When L1≤L≤L2, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is normal, and the adjusted plasma disinfection chamber is not corrected; When L<L1, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is low, and the adjusted plasma disinfection chamber is not corrected; When L>L2, it is determined that the concentration of pathogens entering the plasma disinfection chamber is high, and the adjusted plasma disinfection chamber is corrected by increasing the disinfection power P of the plasma disinfection chamber, and the disinfection power of the corrected plasma disinfection chamber is set to PL, PL=0.82+e 0.5×[(L-L0)+18] ×P.

5. The system for treating pollutants in a biomedical tuberculosis ward according to claim 4, characterized in that: The disinfection control module compares the patient's cough frequency K with the preset patient cough frequency K0, judges the relationship between the patient's cough frequency and the concentration of pathogens entering the plasma disinfection chamber according to the comparison result, and optimizes the process of the calibrated and adjusted plasma disinfection chamber according to the judgment result, wherein: When K≤K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be that the patient's cough frequency is low frequency, which does not affect the concentration of pathogens entering the plasma disinfection chamber, and the process of the plasma disinfection chamber after correction and adjustment is not optimized; When K>K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be high frequency, the pathogen concentration entering the plasma disinfection chamber is increased, and the pathogen concentration L in the plasma disinfection chamber after correction and adjustment is optimized. The optimized pathogen concentration is set as Lk, Lk=[0.77+e 0.62×[(K-K0)+3] ]×L.

6. The system for treating pollutants in a biomedical tuberculosis ward according to claim 5, characterized in that: The disinfection control module compares each therapeutic drug concentration Y1, Y2, Y3, ..., Yn with the preset therapeutic drug concentrations Y01, Y02, Y03, ... Y0n, judges whether each therapeutic drug concentration meets the standard according to the comparison result, and adjusts the metering pump according to the judgment result, wherein: When Y1<Y10, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy1 of the therapeutic drug delivered by the metering pump each time is adjusted to Vminy1, where Vminy1=1.5×Vy1; When Y1=Y10, the concentration of the therapeutic drug is determined to be appropriate, and the metering pump is not adjusted; When Y1>Y10, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy1 of the therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy1, Vmaxy1=0.5×Vy1; When Y2<Y20, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy2 of the therapeutic drug delivered by the metering pump each time is adjusted to Vminy2, Vminy2=1.5×Vy2; When Y2=Y20, the concentration of the therapeutic drug is determined to be appropriate, and the metering pump is not adjusted; When Y2>Y20, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy2 of the therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy2, Vmaxy2=0.5×Vy2; When Y3<Y30, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy3 of the therapeutic drug delivered by the metering pump each time is adjusted to Vminy3, Vminy3=1.5×Vy3; When Y3=Y30, the concentration of the therapeutic drug is determined to be appropriate, and the metering pump is not adjusted; When Y3>Y30, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy3 of the therapeutic drug delivered by the metering pump each time is adjusted to Vmaxy3, Vmaxy3=0.5×Vy3; …… When Yn<Yn0, it is determined that the concentration of the therapeutic drug is too low, and the volume Vyn of the therapeutic drug delivered by the metering pump each time is adjusted to Vminyn, where Vminyn=1.5×Vyn; When Yn=Yn0, the concentration of the therapeutic drug is determined to be appropriate, and the metering pump is not adjusted; When Yn>Yn0, it is determined that the concentration of the therapeutic drug is too high, and the volume Vyn of the therapeutic drug delivered by the metering pump each time is adjusted to Vmaxyn, where Vmaxyn=0.5×Vyn.

7. The system for treating pollutants in a biomedical tuberculosis ward according to claim 6, characterized in that: The disinfection control module compares the patient's drug acceptance J with the preset acceptance J0, judges the patient's treatment effect according to the comparison result, and corrects the preset concentration of each therapeutic drug according to the judgment result, wherein: When J≥J0, the patient's treatment effect is determined to be satisfactory, and no correction is made to the preset concentrations of therapeutic drugs; When J<J0, it is determined that the treatment effect of the patient is not up to standard, and the preset concentrations of the therapeutic drugs are corrected. The preset concentrations of the therapeutic drugs after correction are set to Yj01, Yj02, Yj03, ..., Yj0n, and the calculation formulas are Yj01=1.68e J-J0 +2J+Y01,Yj02=1.68e J-J0 +2J+Y02,Yj03=1.68e J-J0 +2J+Y03、……、Yj0n=1.68e J-J0 +2J+Y0n.

8. The system for treating pollutants in a biomedical tuberculosis ward according to claim 7, characterized in that: The disinfection control module compares the atomized drug temperature W with the preset minimum atomized drug temperature W1 and the preset maximum atomized drug temperature W2, judges the credibility of the patient's drug acceptance according to the comparison result, and regulates the heating wire according to the judgment result, wherein: When W1≤W≤W2, it is determined that the credibility of the patient's drug acceptance meets the standard, and the heating wire is not regulated; When W<W1, it is determined that the credibility of the patient's drug acceptance is not up to standard, and the heating wire is regulated to increase the temperature W of the atomized drug until the credibility of the patient's drug acceptance is up to standard; When W>W2, it is determined that the credibility of the patient's drug acceptance is not up to standard, and the heating wire is regulated to reduce the temperature W of the atomized drug until the credibility of the patient's drug acceptance is up to standard.

9. The system for treating pollutants in a biomedical tuberculosis ward according to claim 2, characterized in that: The treatment feedback module compares the pathogen concentration L0 entering the plasma disinfection chamber after the preset treatment time with the preset patient recovery exhaled pathogen concentration L03, judges the actual treatment situation of the patient according to the comparison result, and outputs according to the judgment result, wherein: When L=0, the actual treatment situation of the patient is judged as the actual exhaled pathogen concentration of the patient is 0, the patient has been successfully cured, and the output is the end of treatment; When L≤L03, the actual treatment situation of the patient is judged as the concentration of pathogens actually exhaled by the patient is reduced, the patient's condition is alleviated, and the output is to maintain treatment; When L>L03, the actual treatment situation of the patient is determined to be that the concentration of pathogens actually exhaled by the patient increases and the patient's condition worsens. The output is to adjust the time the patient wears the breathing mask. The original time the patient wears the breathing mask is set to T0, and the adjusted time the patient wears the breathing mask is set to T0`, T0`=T0+(L-L03) / L.

10. The system for treating pollutants in a biomedical tuberculosis ward according to claim 2, characterized in that: The gas discharge module compares the concentration of pathogens Lp in the gas discharged from the plasma disinfection chamber with the preset concentration of pathogens Lp0 in the gas discharged, judges whether the concentration of pathogens Lp in the gas discharged from the plasma disinfection chamber meets the discharge standard according to the comparison result, and controls the exhaust port according to the judgment result, wherein: When Lp≤Lp0, it is determined that the concentration of pathogens Lp in the gas discharged from the plasma disinfection chamber reaches the discharge standard, and the gas discharge module controls the exhaust port to open to discharge the gas discharged from the plasma disinfection chamber; When Lp>Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber does not reach the discharge standard, and the gas discharge module controls the exhaust port to be closed, and retransmits the gas discharged from the plasma disinfection chamber to the ultraviolet disinfection chamber for disinfection.

Images